Tuberculosis remains one of the world's leading global health threats, killing more than 4,000 people each day. Today's treatments cannot most effectively combat the pandemic because they are too long and complex, and poorly effective against drug-resistant TB.
TB Alliance's ultimate vision is to have a transformative impact on the disease by introducing an ultra-short, simple, and affordable TB regimen that works in virtually all people with tuberculosis. A multi-drug regimen with such broad utility would have a major impact on the global epidemic, saving millions of lives.
To achieve this impact, new regimens must be Adopted, Available, and Affordable.
To read more about out